Plain-English translation of NCT06274034 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing the MUSE S headband—a wearable device that uses brain activity feedback to guide meditation—combined with a smartphone app to help breast cancer survivors reduce anxiety and sleep problems. Researchers want to see if using this device nightly and meditating for just a few minutes each day can truly make a difference for people who've experienced cancer treatment.
Many breast cancer survivors struggle with anxiety and insomnia long after treatment ends, which can hurt their quality of life. This trial explores whether an affordable, easy-to-use meditation device could help fill that gap and offer survivors a practical tool for managing stress and sleep without additional medication.
You likely qualify if…
You likely don't qualify if…
Over 8 weeks, you would wear the MUSE S headband to bed every night and use the companion smartphone app to meditate for at least 5 minutes during the day. The headband gives you real-time feedback on your brain activity during meditation, helping guide you toward a calmer state. You'll track how often you use the device and complete surveys about your anxiety and sleep quality before, during, and after the study.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United States